164 related articles for article (PubMed ID: 37934060)
1. BHLHE40 Mediates Cross-Talk between Pathogenic TH17 Cells and Myeloid Cells during Experimental Autoimmune Encephalomyelitis.
Cook ME; Shchukina I; Lin CC; Bradstreet TR; Schwarzkopf EA; Jarjour NN; Webber AM; Zaitsev K; Artyomov MN; Edelson BT
Immunohorizons; 2023 Nov; 7(11):737-746. PubMed ID: 37934060
[TBL] [Abstract][Full Text] [Related]
2. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation.
Lin CC; Bradstreet TR; Schwarzkopf EA; Jarjour NN; Chou C; Archambault AS; Sim J; Zinselmeyer BH; Carrero JA; Wu GF; Taneja R; Artyomov MN; Russell JH; Edelson BT
J Exp Med; 2016 Feb; 213(2):251-71. PubMed ID: 26834156
[TBL] [Abstract][Full Text] [Related]
3. Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation.
Lin CC; Bradstreet TR; Schwarzkopf EA; Sim J; Carrero JA; Chou C; Cook LE; Egawa T; Taneja R; Murphy TL; Russell JH; Edelson BT
Nat Commun; 2014 Apr; 5():3551. PubMed ID: 24699451
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome Proliferator-Activated Receptor-δ Acts within Peripheral Myeloid Cells to Limit Th Cell Priming during Experimental Autoimmune Encephalomyelitis.
Drohomyrecky PC; Doroshenko ER; Akkermann R; Moshkova M; Yi TJ; Zhao FL; Ahn JJ; McGaha TL; Pahan K; Dunn SE
J Immunol; 2019 Nov; 203(10):2588-2601. PubMed ID: 31578267
[TBL] [Abstract][Full Text] [Related]
5. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
6. GATA3 induces the pathogenicity of Th17 cells via regulating GM-CSF expression.
Butcher MJ; Gurram RK; Zhu X; Chen X; Hu G; Lazarevic V; Zhao K; Zhu J
Front Immunol; 2023; 14():1186580. PubMed ID: 37449212
[TBL] [Abstract][Full Text] [Related]
7. IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier.
Lee MJ; Bing SJ; Choi J; Jang M; Lee G; Lee H; Chang BS; Jee Y; Lee SJ; Cho IH
Mol Neurodegener; 2016 Jul; 11(1):54. PubMed ID: 27450563
[TBL] [Abstract][Full Text] [Related]
8. High salt drives Th17 responses in experimental autoimmune encephalomyelitis without impacting myeloid dendritic cells.
Jörg S; Kissel J; Manzel A; Kleinewietfeld M; Haghikia A; Gold R; Müller DN; Linker RA
Exp Neurol; 2016 May; 279():212-222. PubMed ID: 26976739
[TBL] [Abstract][Full Text] [Related]
9. Functional characteristics of Th1, Th17, and ex-Th17 cells in EAE revealed by intravital two-photon microscopy.
Loos J; Schmaul S; Noll TM; Paterka M; Schillner M; Löffel JT; Zipp F; Bittner S
J Neuroinflammation; 2020 Nov; 17(1):357. PubMed ID: 33243290
[TBL] [Abstract][Full Text] [Related]
10. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
11. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G
PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700
[TBL] [Abstract][Full Text] [Related]
12. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
[TBL] [Abstract][Full Text] [Related]
13. MW‑9, a chalcones derivative bearing heterocyclic moieties, attenuates experimental autoimmune encephalomyelitis via suppressing pathogenic T
Liu B; Mao Z; Yin N; Gu Q; Gu Q; Qi Y; Li X; Yang H; Wu Z; Zou N; Ying S; Wan C
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35959804
[TBL] [Abstract][Full Text] [Related]
14. miR-485 regulates Th17 generation and pathogenesis in experimental autoimmune encephalomyelitis through targeting STAT3.
Xue Y; Zhang L; Guo R; Shao X; Shi M; Yuan C; Li X; Li B
J Neuroimmunol; 2023 Jun; 379():578100. PubMed ID: 37187004
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
16. Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming.
Fernández M; Monsalve EM; López-López S; Ruiz-García A; Mellado S; Caminos E; García-Ramírez JJ; Laborda J; Tranque P; Díaz-Guerra MJM
Eur J Immunol; 2017 Dec; 47(12):2090-2100. PubMed ID: 28762472
[TBL] [Abstract][Full Text] [Related]
17. Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice.
Zhang H; Bi J; Yi H; Fan T; Ruan Q; Cai L; Chen YH; Wan X
Immunol Cell Biol; 2017 Aug; 95(7):593-600. PubMed ID: 28202908
[TBL] [Abstract][Full Text] [Related]
18. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
19. S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Mazroua HA; Alomar HA; Al-Hamamah MA; Attia SM
Mult Scler Relat Disord; 2023 May; 73():104658. PubMed ID: 36989705
[TBL] [Abstract][Full Text] [Related]
20. CD44 Reciprocally regulates the differentiation of encephalitogenic Th1/Th17 and Th2/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmune encephalomyelitis.
Guan H; Nagarkatti PS; Nagarkatti M
J Immunol; 2011 Jun; 186(12):6955-64. PubMed ID: 21551360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
